Dry Eye
CLIDE-proof CLs?
Researchers at the Terasaki Institute for Biomedical Innovation (TIBI), US, developed a prototype contact lens designed to prevent contact lens-induced dry eye (CLIDE) by facilitating tear flow in
Staff reporters1 min read
Anti-VEGF for DED?
Researchers in Norway have found that repeated intravitreal injections (IVI) with anti-vascular endothelial growth factor (anti-VEGF) improved some dry-eye disease symptoms in patients with neovascular age-related macular degeneration (nAMD).
Staff reporters1 min read
Review shows omega-3 benefits DED
Despite conflicting results from previous studies, a new review of 152 publications concluded topical omega-3 is a promising treatment option for dry eye disease (DED) and other ocular surface inflammatory disease.
Staff reporters1 min read
Doxycycline for lower IOP?
A US pilot study has shown that low-dose doxycycline, an antibiotic with anti-inflammatory characteristics used to treat bacterial infections, meibomian gland dysfunction and rosacea, may be a useful adjunct therapy for intraocular pressure (IOP) reduction.
Staff reporters2 min read
Oculoplastic research review
Telemedicine in oculoplastic and adnexal surgery: clinicians’ perspectives in the UK
Dr Simon Dean4 min read
Glaukos’ trials update
California-based ophthalmic medical company Glaukos announced promising topline results from its phase 2a first-in-human clinical trial for GLK-301 (iLution), a sterile topical cream to treat dry eye disease (DED). The cream formulation acts as a depot allowing pilocarpine to be delivered through th
Staff reporters2 min read
AAO’s centennial celebration and local honouree!
After almost three years of Covid restrictions on international travel, it was such a pleasure to join thousands of in-person attendees at the San Diego Convention Centre for the four-day American Academy of Optometry (AAO) 2022 meeting.
Dian Zhuang6 min read
Water-free DED treatment nears approval
Novaliq has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for CyclASol, which it describes as a first-of-its-kind anti-inflammatory product for the treatment of dry eye disease (DED).
Staff reporters1 min read
Trial success for MGD drug
Israel’s Azura Ophthalmics announced positive three-month efficacy and safety results from its phase 2b study on its keratolytic eye preparation AZR-MD-001 0.5% in meibomian gland dysfunction (MGD).
Staff reporters1 min read
Update on refractive surgery
There was a time when refractive surgery was very much the domain of those surgeons who specifically specialised in excimer laser treatment of the cornea, but rapid advances in corneal refractive surgery techniques and intraocular lens (IOL) technology, as well as greater patient expectations, have
Dr Sue Ormonde10 min read
New eye drops for pre- and post-cataract surgery
Boosting its dry eye family of products, Medix21 has introduced Rayner’s Aeon pre- and post-surgery eye drops to help manage patients’ dry eye and improve visual outcomes.
Staff reporters2 min read